Copy number and nucleotide variation of the LILR family of myelomonocytic cell activating and inhibitory receptors by unknown
ORIGINAL PAPER
Copy number and nucleotide variation of the LILR family
of myelomonocytic cell activating and inhibitory receptors
María R. López-Álvarez & Des C. Jones & Wei Jiang &
James A. Traherne & John Trowsdale
Received: 12 September 2013 /Accepted: 24 October 2013 /Published online: 21 November 2013
# The Author(s) 2013. This article is published with open access at Springerlink.com
Abstract Leukocyte immunoglobulin-like receptors (LILR)
are cell surface molecules that regulate the activities of
myelomonocytic cells through the balance of inhibitory and
activation signals. LILR genes are located within the leuko-
cyte receptor complex (LRC) on chromosome 19q13.4 adja-
cent to KIR genes, which are subject to allelic and copy
number variation (CNV). LILRB3 (ILT5) and LILRA6
(ILT8) are highly polymorphic receptors with similar extra-
cellular domains. LILRB3 contains inhibitory ITIM motifs
and LILRA6 is coupled to an adaptor with activating ITAM
motifs. We analysed the sequences of the extracellular immu-
noglobulin domain-encoding regions of LILRB3 and LILRA6
in 20 individuals, and determined the copy number of these
receptors, in addition to those of other members of the LILR
family.We found 41 polymorphic sites within the extracellular
domains of LILRB3 and LILRA6 . Twenty-four of these sites
were common to both receptors. LILRA6 , but not LILRB3 ,
exhibited CNV. In 20 out of 48 human cell lines from the
International Histocompatibility Working Group, LILRA6
was deleted or duplicated. The only other LILR gene
exhibiting genomic aberration was LILRA3 , in this case due
to a partial deletion.
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Introduction
Leukocyte immunoglobulin (Ig)-like receptors (LILR; also
termed LIR or ILT) are mainly expressed on the surface of
myelomonocytic cells (Brown et al. 2004) and they have been
shown to be important mediators of immunological tolerance
(Manavalan et al. 2003; Kim-Schulze et al. 2006). They have
been proposed to regulate the function of Toll-like receptors
(TLR) and to alter the phenotype and profile of cytokine produc-
tion by antigen presenting cells (Chang et al. 2002, 2009;
Anderson and Allen 2009; Brown et al. 2009), thereby control-
ling both innate and adaptive immune responses. Their func-
tions have been linked to control of bacterial and viral infec-
tion (Brown et al. 2009; Lee et al. 2007; Pilsbury et al. 2010).
LILRs are genetically associated with autoimmune diseases
such as multiple sclerosis (Koch et al. 2005; Ordóñez et al.
2009), Sjögren's syndrome (Kabalak et al. 2009), and rheu-
matoid arthritis (Kuroki et al. 2005; Huynh et al. 2007).
LILR receptors can be classified into two main groups,
LILRA and LILRB. The LILRA group includes genes that
have truncated cytoplasmic tails and associate with the γ-
chain of FcεRI through a charged arginine residue in the
transmembrane domain, delivering an activating signal
through an immunoreceptor tyrosine-based activation motif
(ITAM) (Nakajima et al. 1999). One exception is LILRA3, a
soluble protein that has no known signalling ability (Borges
et al. 1997; Colonna et al. 1999). On the other hand, LILRB
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proteins have long cytoplasmic tails with immunoreceptor
tyrosine-based inhibitory motifs (ITIM). Some LILR recep-
tors interact with HLA class I (Group 1: LILRB1, -B2, -A1, -
A2 and -A3) and they share significant amino acid sequence
homology over class I-binding regions (Borges et al. 1997;
Colonna et al. 1998; Fanger et al. 1998; Willcox et al. 2003).
The ligands for the other receptors, including LILRB3-B5 and
LILRA5-A6 are unknown, except for LILRA4 which binds
CD317 (Cao et al. 2009; Tavano et al. 2013). These receptors
contain non-conservative substitutions in class I binding re-
gions identified in group 1(Willcox et al. 2003).
LILR are encoded within the leukocyte receptor complex
(LRC) on chromosome 19q13.4 (Fig. 1), adjacent to the
related killer immunoglobulin (Ig)-like receptor (KIR) genes
(Barrow and Trowsdale 2008). KIR genes exhibit consider-
able sequence polymorphism (Robinson et al. 2010) and
extensive copy number variation (CNV) (Jiang et al. 2012).
LILRB3 and LILRA6 are paired receptors which potentially
deliver opposing signals. The genes encoding these receptors
display remarkable diversity within their extracellular
domains when compared to either LILRB1 or LILRB2
(Colonna et al. 1997). For example, there is evidence for
variation in the number of copies of LILRA6 (Sudmant et al.
2010). In addition, it has been reported that some individuals
lack LILRA3 gene expression as a consequence of a large
deletion of 6.7 kbp, resulting in the removal of four Ig domain
and two leader peptide exons from the genomic sequence
(Torkar et al. 2000).
To gain insight into the genetics and functions of the
polymorphic LILR that do not bind class I, we characterised




Sequencing analysis was performed in cDNA samples from
20 healthy individuals from the Cambridge Blood Centre.
Informed consent was obtained from all individuals. CNV
assay was carried out in DNA samples from 48 human cell
lines from the International Histocompatibility Working
Group from different ethnic origins (see Table S1).
Sequencing
RNA extraction and subsequent cDNA synthesis was performed
as described previously (Jones et al. 2009). Transcripts were
initially amplified from macrophage cDNA using primers
NK1078 and NK1091 for LILRB3 (see Table S2 for primer
details) and, NK1078 and NK636 for LILRA6 . These initial
polymerase chain reactions (PCRs) were performed using
Phusion polymerase (Finnzymes) with the following cycling
parameters: 30 s at 98 °C followed by 35 cycles of 98 °C for
10 s, 68 °C for 30 s, and 72 °C for 60 s. All PCRs were
performed on the MJ Research (Reno, NV, USA) PTC-200
thermal cycler. Products were assessed by cycle sequencing
using BigDye Terminator version 3.1 methodology (Applied
Biosystems) and an Applied Biosystems 3730xl DNA analyser
using the primers NK1078 and NK1495 (LILRB3), or NK1078,
NK1404 and NK1494 (LILRA6) (Table S2).
To determine the sequences of single alleles within hetero-
zygote individuals, we performed PCRs on individual
cDNAs, using forward primers with specificity for single
nucleotide polymorphisms (SNPs) (Table S2). These SNP-
specific primers (SSP) were used in conjunction with either
the LILRB3-specific reverse primer NK1091 or the LILRA6-
specific NK636. The cycling conditions were: 180 s at 96 °C,
followed by 5 cycles of 96 °C for 20 s, 70 °C for 45 s, and
72 °C for 25 s. This was followed by 31 cycles of 96 °C for
25 s, 65 °C for 50 s and 72 °C for 30 s; followed by 4 cycles of
96 °C for 30 s, 55 °C for 60 s and 72 °C for 90 s. All amplicons
from PCR-SSP carried an M13R tag at the 5′ end, which was
exploited for subsequent cycle sequencing using the primers
M13R, in addition to NK1495, NK1404 and NK1494.
Sequence analysis: calculation of dN/dS ratios and statistical
tests
To assess putative evolutionary selection pressure on poly-
morphism acting on the extracellular immunoglobulin-like
region of LILRB3 and LILRA6 alleles, non-synonymous
(dN) and synonymous (dS) substitution rates for all pairwise
Fig. 1 LILR genes. The LILR family is located in the LRC on chromo-
some 19q13.4 neighbouring the KIR family of genes. It is composed of
two inverted clusters separated by LAIR and other genes. The
transcription of each of these LILR clusters is in a head to tail fashion,
as indicated by the arrows
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comparisons of alleles from both loci were calculated using
the KaKs Calculator (Zhang et al. 2006), applying Nei and
Gojobori's method and incorporating Jukes–Cantor correction
(Nei and Gojobori 1986).
One-tailed Fisher's exact tests for positive selection for
sequence pairs were performed on the entire extracellular Ig
region of LILRB3 and LILRA6 using Graphpad (http://www.
graphpad.com/quickcalcs/) as previously described (Zhang
et al. 1997). Results were considered statistically significant
with p <0.05.
Quantitative PCR
LILR copy number was determined by quantitative PCR
(qPCR), on genomic DNA extracted from 48 human
cell lines from the International Histocompatibility
Working Group (http://www.ihwg.org/hla/) using the
QIAamp DNA Blood Midi Kit (QIAGEN) following
the manufacturer's instructions. The following genes
were typed for CNV: LILRA1 , LILRA2 , LILRA3 ,
LILRA4 , LILRA5 , LILRA6 , LILRB1 , LILRB2 , LILRB3 ,
LILRB4 and LILRB5 .
Forward and reverse primers, and a dual-labelled probe
were designed to specifically amplify each LILR gene
(Table S3), avoiding any allelic variation identified to
date. LILR sequences were analysed for specificity
using the primerBLAST tool from the National Centre
for Biotechnology Information (http://www.ncbi.nlm.nih.gov/
tools/primer-blast). In addition, all reactions contained
specific primers and a probe for the STAT6 gene, which has
two copies per diploid human genome, and was used as an
endogenous reference gene. All reactions were performed in
quadruplicate for each sample to increase the accuracy of copy
number scoring.
A total of 10 ng of genomic DNAwas amplified under the
following PCR conditions: 5 min at 95 °C; followed by
40 cycles of 95 °C for 15 s and 66 °C for 50s; followed by
10s at 40 °C, using the LightCycler 480 System (Roche
Diagnostics Ltd., Burgess Hill, UK). LILR copy number
was determined by a quantitative PCR comparative Ct method
(Schmittgen and Livak 2008).
SSP-PCR genotyping
Genotyping for presence of the SNP that encodes a threonine
(T) at residue 94 within LILRA6 was performed on genomic
DNA samples using the primer pair NK1513 (5′-CCCCCT
GGAGCTGGTGAC-3′) and NK559 (5′-TCATCAGAACAA
AATGGTGATATCT-3′) or NK560 (5′-CATCAGAACAAA
ATGGTGATATCC-3′). Detection of a 570-bp deletion locat-
ed within the intergenic region between LILRA6 and LILRB3
was performed using the primer pair NK1520 (5′-CTGGTC
CCTGCAGTGGCA-3′) and NK1518 (5′- GCCTTAGACT
TCCTATCCTGAAAC-3′). PCR cycling conditions were as
previously described (Jones et al. 2006).
Results
LILRB3 and LILRA6 immunoglobulin-like domains are
highly polymorphic
By exploiting polymorphic sites and unique regions within the
3′ ends of LILRB3 and LILRA6 , we were able to characterise
the sequences encoding the Ig domains of single alleles.
This approach made it possible to identify individual
allele sequences regardless of any variation in copy
number (see later).
Analysis of the extracellular Ig domain-coding regions of
the LILRB3 and LILRA6 genes, using cDNA samples from 20
healthy individuals, identified substantial variation in the
nucleotide sequences of both receptors (Tables 1 and 2).
This analysis generated 25 different sequences, 21 of
which were novel and have subsequently been deposited
in Genbank with accession numbers from KF294233 to
KF294253.
We elucidated a total of 41 variable nucleotides in LILRB3
and LILRA6 sequences. Twenty-one of the non-synonymous
and three of the synonymous substitutions affected the same
nucleotide position in the coding sequence of both genes.
None of these polymorphisms displayed significant linkage
disequilibrium between LILRB3 and LILRA6 alleles (data not
shown). The inhibitory receptor LILRB3 encompassed 40
polymorphic sites with 34 non-synonymous and six synony-
mous substitutions. The activating receptor LILRA6 showed
less variation; 29 polymorphic sites, of which 25 were non-
synonymous and four synonymous substitutions (Tables 1
and 2). Moreover, the analysis of these cDNA sequences
revealed that four individuals carried three alleles of
LILRA6 , of which LILRA6*01 and *03 were common to
all the samples and in three out of the four samples, the
third allele was LILRA6*04. LILRA6*03 was present in the
cDNA samples of all individuals with three alleles and it
was the only LILRA6 allele with the SNP 94 T (Table 1),
suggesting that this SNP correlated with the increase in the
number of copies of LILRA6 . We performed SSP-PCR to
detect the polymorphism at position 94 in the genomic
DNA samples from cell lines but did not find any associ-
ation between the presence of T at position 94 and the
increase in the number of copies of LILRA6 in our cohort
(Table 3).
Protein evolution by selective pressure can be measured by
considering the replacement of nucleotides within codons and
by analysing site-by-site the dN/dS substitution ratio between
sequences (Yang et al. 2000). This analysis can reveal the
presence of either strictly conserved (dN/dS <1) or rapidly
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evolving regions in genes (dN/dS >1). LILRB3 and LILRA6
sequences displayed in Tables 1 and 2 were analysed in this
manner. There were predominantly non-synonymous poly-
morphisms, so the dN/dS ratios were consistent with positive
selection (Fig. 2).
LILRA3 and LILRA6 genes, but not LILRB3 , show variation
in copy number
We designed assays to detect variation in the number of copies
of LILR genes by qPCR. CNV was detected in the LILRA3
and LILRA6 loci (Fig. 3c and f, respectively). LILRA3 varied
between zero, one or two copies per diploid genome. Around
21 % of the samples lacked LILRA3 , while ~19 % had only
one copy of this gene. CNV in LILRA6 varied between one,
two, three and four copies per diploid genome; ~8 % of the
samples had a single copy of the gene, whilst ~33 % carried a
duplication of LILRA6 (three or four copies). Despite its high
rate of allelic variation, LILRB3 had a constant number of two
copies per genotype (Fig. 4c).
We identified a fosmid sequence deposited in Genbank
(accession number: AC236241) that contains two sequences
of LILRA6 , the arrangement of which is represented in Fig. 5.
The additional LILRA6 locus (LILRA6 [2]) occurred ~15 kb
upstream of the common LILRA6 locus (LILRA6 [1]) within
the region normally occupied by LILRB3 . Sequence
AC236241 also possesses a deletion within a tandem repeat
sequence that is normally located within the intergenic region
between LILRA6 and LILRB3 . We used the Tandem repeats
finder program (Benson 1999) to detect the 33-bp tandem
repeat sequence, which has a consensus sequence of TCTA
TTGAGATCCTATGGAGGTCCTGTGGGGGT and a copy
Table 2 Synonymous polymorphism within the extracellular Ig-coding region of LILRB3 and LILRA6 alleles
Ig 1 Ig 2 Ig 3 Ig 4
70(A) 98(Y) 267(H/N/Y)a 274(Y) 287(S) 326(G)a 392(E)
Allele GCG TAC H: CAC TAT AGC G: GGG GAA
LILRB3 01 - - - - - - H: - - - - - - - - - W - - -
01 - - - - - - H: - - - - - - - - - W - - -
03 - - - - - - H: - - - - - - - - - W - - -
04 - - - - - - N: A - T - - - - - - W - - -
05 - - A - - - N: A - T - - C - - - W - - G
06 - - A - - - N: A - T - - C - - - W - - -
07 - - - - - - H: - - - - - - - - - W - - -
08 - - - - - - H: - - - - - - - - - W - - -
09 - - - - - - H: - - - - - - - - - W - - -
10 - - A - - T N: A - T - - C - - - W - - G
11 - - A - - - N: A - T - - - - - - W - - G
12 - - A - - - Y: T - - - - - - - T G: - - - - - -
13 - - A - - - Y: T - - - - - - - T G: - - - - - -
14 - - A - - - Y: T - - - - - - - T G: - - - - - -
LILRA6 01 - - - - - T H: - - - - - - - - - W - - -
02 - - A - - T H: - - - - - - - - - W - - -
03 - - A - - - H: - - - - - - - - - G: - - T - - -
04 - - A - - - H: - - - - - - - - - G: - - T - - -
05 - - A - - - H: - - - - - - - - - G: - - T - - -
06 - - A - - - H: - - - - - - - - - G: - - T - - G
07 - - A - - - Y: T - - - - - - - - G: - - T - - G
08 - - A - - - Y: T - - - - - - - - G: - - T - - -
09 - - A - - - Y: T - - - - - - - - G: - - T - - G
10 - - A - - - Y: T - - - - - - - - G: - - - - - -
11 - - A - - - Y: T - - - - - - - - G: - - - - - -
Residue number, amino acid and codon sequences are displayed (residues are numbered in relation to the predicted mature protein sequence). In all cases,
synonymous polymorphism occurs at the third position within each codon (underlined)
a Sites where both synonymous and non-synonymous polymorphisms occur in conjunction
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number of 19.9. This repeat was absent from AC236241. By
utilising PCR primers that flank this deletion (Fig. 5b), we
found that its presence correlated strongly with the duplication
of LILRA6 within our cohort, occurring in around 93 % of the
samples with more than two copies of LILRA6 (Table 3),
indicating that fosmid AC236241 represents a commonly
occurring haplotype that carries a duplication of LILRA6 .
No other LILR gene shows CNV
To determine whether the CNV we observed was a more
widespread feature of LILR genes, we carried out CNVanal-
ysis of all other activating and inhibitory LILR genes
(LILRA1 , -A2 , -A4 , -A5 , -B1 , -B2 , -B4 and -B5 ). This
analysis did not identify any further variation in the number
Table 3 LILRA6 CNVand pres-
ence of tandem repeat sequence
and SNP 94 T
CN calculated copy number, TRS
tandem repeat sequence
Cell line CN TRS 94 T Cell line CN TRS 94 T
KT12 2.89 Deletion Negative RSH 3.32 Deletion Negative
TAB089 2.06 Complete Negative TL 3.04 Deletion Positive
XL1-ND 2.31 Complete Negative PAR 2.06 Complete Negative
RML 3.02 Deletion Negative WT24 3.19 Deletion Positive
KY 1.68 Complete Negative SA 2.10 Complete Positive
HOM2 1.76 Complete Negative LATIF 1.86 Complete Negative
KT17 2.01 Deletion Negative OZB 1.05 Complete Negative
JESTHOM 1.98 Complete Negative AMAI 2.84 Complete Positive
AKIBA 1.92 Complete Negative COX 1.96 Complete Positive
WWPAK 1.90 Complete Negative KAS011 0.38 Complete Negative
GRC 3.28 Deletion Negative CO47 2.11 Deletion Positive
BM9 2.27 Complete Negative FPAF 1.97 Deletion Negative
SLE005 2.10 Deletion Positive SNA BLL 2.01 Complete Negative
DUCAF 3.09 Deletion Negative DUGE 2.98 Deletion Negative
PMH 161 2.00 Complete Negative WJR076 1.93 Complete Negative
LB 1.95 Complete Negative VAVY 2.01 Complete Negative
BTB 1.96 Deletion Negative HOR 1.10 Complete Negative
IBW9 3.09 Deletion Positive MANIKA 3.89 Deletion Positive
DKB 3.13 Deletion Positive MGAR 2.32 Deletion Negative
DEM 3.08 Deletion Positive H0104 1.84 Deletion Negative
LBF 2.90 Deletion Positive M7 2.70 Deletion Negative
BOLETH 1.16 Complete Negative LCL 721 2.13 Complete Positive
HO301 2.01 Deletion Positive CRGE 2.04 Complete Negative
31708 3.75 Deletion Negative MCF 1.99 Deletion Positive
Fig. 2 dN/dS ratios of the extracellular regions of LILRB3 and LILRA6
indicate positive selection. a dN and dS values from allelic pairwise
comparisons of each gene, LILRB3 (circles) and LILRA6 (squares),
and inter-gene comparison (triangles). Only sequences detected in
this study were included in the analysis. The central plot line
represents balancing selection (where dN=dS). Shaded symbols indi-
cate significance using a Fisher's exact test for positive selection
pressure (Zhang et al. 1997). b dN and dS values for previously
reported LILRB1 (circles) and LILRB2 (squares) sequences deposited
in Genbank (http://www.ncbi.nlm.nih.gov/genbank/)
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of copies of other LILR genes (Figs. 3 and 4), indicating that
CNV is specific to the LILRA3 and LILRA6 loci, or rare for
other genes.
Discussion
Amplification and sequencing of LILRB3 and LILRA6 cDNA
from 20 individuals returned 25 different sequences with 41
polymorphic sites, consistent with these receptors being high-
ly polymorphic in their extracellular domains (Colonna et al.
1997). Most of variable positions were represented in both
LILRB3 and LILRA6 , including several synonymous
substitutions. This indicates the possibility of genetic transfer
between these two genes and the additional copies of LILRA6 .
The patchwork nature of the variation is reminiscent of the
variation in someMHC class I or class II genes, in which case
it may be achieved by allele or gene conversion (Traherne
et al. 2006). Several non-synonymous polymorphisms within
LILRB3 and LILRA6 occur at positions known to form part of
the binding sites of Group 1 LILR to MHC class I: 36, 38, 67,
97, 99 and 126 (Willcox et al. 2003; Yang and Bjorkman
2008). Although no specific ligand for both LILRB3 and
LILRA6 receptors has yet been identified, it is tempting to
speculate that these variations may have functional conse-
quences. Additionally, we found three alleles of LILRA6 in
Fig. 3 Copy number variation of
activating LILR receptor genes.
Summaries of the results of copy
number assays for LILRA1 (a),
LILRA2 (b), LILRA3 (c),
LILRA4 (d), LILRA5 (e) and
LILRA6 (f). The number of
copies per genome was constant
(two copies) in activating LILR
receptors with the exception of
LILRA3 and LILRA6, which
displayed variation. LILRA3
showed from zero to two copies
per genome. LILRA6 showed
from one to four copies per
genome. Each bar represents the
calculated copy number obtained
for one sample (see Table S1).
Number inside plot is the
predicted copy number for
samples
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four cDNA samples, indicating that the duplicated copies of
this gene are expressed and are presumably functional. The
fact that three out of four samples had the combination of
LILRA6*03 and LILRA6*04 concurs with the duplication of
LILRA6 found in a fosmid (accession number AC236241).
However, this allele pairing was not found in all tri-allelic
individuals. Moreover, the SNP 94 T, characteristic of
LILRA6*03, which was carried by all four individuals with
three alleles, was not associated with the increase in the
number of copies of LILRA6 found in cell lines. Therefore,
it would appear that the allele content within the haplotype
comprising duplicated LILRA6 genes is variable.
The method of CNVanalysis we describe has a number of
advantages: it is simple to carry out, low cost, specific and
sensitive and is high-throughput, as up to a thousand samples
can be analysed per week. Variation in LILR gene copy
Fig. 4 Copy number variation of inhibitory LILR receptor genes. Copy
number variation was analysed for the inhibitory receptor genes LILRB1
(a), LILRB2 (b), LILRB3 (c), LILRB4 (d) and LILRB5 (e). The figure
shows the results of this analysis where each of these receptor genes are
present in two copies per genotype. Each bar represents the calculated
copy number obtained for one sample (see Table S1)
Fig. 5 Genetic organisation of the centromeric region of the LILR gene
cluster encompassing LILRB5, LILRB3 and LILRA6. a Genes are ar-
ranged according to their positions as determined by analysis of the
representative sequence CU151838 (i) and within fosmid AC236241
(ii). Sequence AC236241 carries two copies of LILRA6 (labelled 1 and
2) and a 570-bp deletion within the tandem repeat region present in
CU151838. The comparative homology between these two sequences is
also presented. Regions occurring within both LILRB3 and LILRA6 that
share >95% identity are indicated, together with the locations of LILRA6-
specific sequence within AC236241. The AC236241 sequence termi-
nates within the 3′ region of LILRA6 (2). b PCR-based detection of the
deleted region identified within fosmid AC236241. Amplification of the
tandem repeat sequence between LILRB3 and LILRA6 (918 bp) or two
LILRA6 sequences (348 bp). Samples are DEM (1), DUCAF (2), HOR
(3), and SA (4). The arrow indicates the direction of DNA migration.
Refer to Table 3 for information about the results of LILRA6 copy
number, the deletion within the tandem repeat sequence and results for
the SNP 94 T by SSP-PCR
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number was detectedwithin LILRA3 , which encodes a soluble
molecule (Borges et al. 1997; Colonna et al. 1999), and the
activating LILRA6 , while all inhibitory LILR genes, including
the highly polymorphic LILRB3 , had a constant number of
two copies per diploid genome. The gene frequency of dele-
tion of LILRA3 was around 40 %, in concordance with pre-
viously published results where the frequency of deletions
varied from 6 % to 84 % in different populations (Torkar
et al. 2000; Wiśniewski et al. 2013). LILRA6 was more
variable; 8.3 % of the samples showed a heterozygous dele-
tion of LILRA6 , and in 33.3 % of the cases, we observed
duplications of this gene (three or four copies).
The variation in the number of copies of LILRA6 could be
due to non-allelic homologous recombination (NAHR) or
crossing-over between sequences that are not in allelic posi-
tions, a phenomenon proposed for CNV in KIR (Traherne
et al. 2010). These events are mediated by genomic structures
that are flanked by paralogous repeat sequences, low-copy
repeats, segmental duplications or tandem repeat regions
(Jeffreys et al. 2004; Liu et al. 2012). We found a tandem
repeat sequence between LILRB3 and LILRA6 genes
(Fig. 5a), that was deleted in sequence contained in fosmid
AC236241, which carries a duplication of LILRA6 . Therefore,
it could be hypothesised the deletion within the tandem repeat
region may be mechanistically linked to the duplication event
of LILRA6 within this haplotype. From analysis of the
AC236241 sequence an obvious insertion point of the dupli-
cated LILRA6 gene could not be identified indicating that
unequal crossover could have occurred within the ~4.9-kb
homologous region that LILRA6 shares with LILRB3
(Fig. 5a). Recombination centred upon the repeat region
may account for the lack of significant linkage disequilibrium
observed between alleles of LILRB3 and LILRA6 , as deter-
mined by the analysis of cDNA from 20 individuals (data not
shown).
Our CNV screen indicates that LILRA6 is absent on some
haplotypes. There are two sequences in Genbank (accession
numbers: AC235034 and AC153469) that lack LILRA6 , and
instead carry LILRB3 at that genomic location. The LILRB3
allele within AC235034 encodes a predicted protein sequence
that is identical to LILRA6*01 throughout its extracellular
region, while the predicted protein encoded by AC153469
only differs with LILRA6*01 due to the presence of 164 T.
LILRA6*01 is the most frequently occurring allele according
to our cDNA screen (Table 1) and carries two unique SNPs
(65 I and 120 Q), and a unique combination of variable posi-
tions 36 R, 46 W and 67 E. We did not detect these polymor-
phic features within any LILRB3 allele, suggesting that they
are predominately a characteristic of LILRA6 . Their presence
within the LILRB3 sequences of AC153469 and AC235034 is
evidence of an unequal crossover event that has occurred
within the homologous region following the Ig2-encoding
exon of LILRA6 , resulting in the replacement of LILRA6 -
specific sequence within the 3′ of the gene with that of
LILRB3 . This indicates that unequal crossover is a mechanism
by which genetic information may be exchanged between
these two genes (Fig. 6a). An additional possibility could be
the formation of single-stranded DNA (ssDNA) secondary
structures or hairpin loops in the repeat tandem sequence
(Fig. 6b). These structures are accessible substrates for nucle-
ases, making them susceptible to strand breaks. This may lead
to repair processes that can cause deletion of regions or genetic
transfer of homologous sequences between chromosomes.
Such recombination processes have previously been proposed
in the evolution of the KIR gene cluster (Traherne et al. 2010).
Functionally, the increase in the number of copies of
LILRA6 could affect the balance between activating and in-
hibitory signals after ligand binding. How could the combina-
tion of CNVand variable sequences be interpreted in terms of
function? So far, it is difficult to identify haplotype-specific
combinations of variable sequences over the sets of genes, as
we do not have sequence information over single haplotypes.
If these exist they would be consistent with haplotype-specific
interactions with a ligand and integration of signals from the
different receptors, as may be the case for some neighbouring
KIR A and B haplotypes. They would suggest that the
Fig. 6 Non-allelic homologous recombination and potential ssDNA
secondary structures produced at the tandem repeat sequence. a The
process of unequal crossing-over of homologous sequences proposed to
generate deletions (i) or duplications (ii) of LILRA6 . b Seventeen hairpin
structures were predicted using the Mfold program (Zuker 2003). Twenty
copies of the repeat tandem sequence TCTATTGAGATCCTATGGAG
GTCCTGTGGGGGTwas used as the input
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constellations of variable activating and inhibitory receptors
on haplotypes are driven by interaction with a variable ligand,
such as a variable pathogen.
In conclusion, we have shown high levels of polymor-
phism and homology between LILRB3 and LILRA6 in their
extracellular domains, with LILRA6 also displaying alter-
ations in the number of copies. All the variations observed
in these genes may affect ligand binding, the equilibrium
between activating and inhibitory signals, and therefore, the
balance of immune response. The allelic variation and CNVin
the LILRB3/LILRA6 pair we have described is consistent
with strong selection for variation and high dN/dS ratios
are characteristic of other immune system genes, such as
MHC or KIR, that are involved with resistance to pathogens
(Park et al. 2012).
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